Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Pulmonary pharmacology and therapeutics

  • Pulmonary pharmacology and therapeutics
  • Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells
    Sebastian Vencken, Camilla Foged, Joanne M. Ramsey, Louise Sweeney, Sally-Ann Cryan, Ronan J. MacLoughlin, Catherine M. Greene
    ERJ Open Research Apr 2019, 5 (2) 00161-2018; DOI: 10.1183/23120541.00161-2018
  • Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study
    Konstantinos Kostikas, Timm Greulich, Alexander J. Mackay, Nadine S. Lossi, Maryam Aalamian-Mattheis, Xavier Nunez, Veronica A. Pagano, Francesco Patalano, Andreas Clemens, Claus F. Vogelmeier
    ERJ Open Research Feb 2019, 5 (1) 00243-2018; DOI: 10.1183/23120541.00243-2018
  • Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
    Lowie E.G.W. Vanfleteren, Anders Ullman, Anita Nordenson, Anders Andersson, Kristina Andelid, Leonardo M. Fabbri
    ERJ Open Research Feb 2019, 5 (1) 00185-2018; DOI: 10.1183/23120541.00185-2018
  • Valved holding chamber drug delivery is dependent on breathing pattern and device design
    Péter Csonka, Lauri Lehtimäki
    ERJ Open Research Feb 2019, 5 (1) 00158-2018; DOI: 10.1183/23120541.00158-2018
  • Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial
    James D. Chalmers, Remco S. Djamin, Marjolijn Schouten, Holly R. Keir, Brandon Tan, Joachim G.J.V. Aerts, Jeffrey T-J. Huang, Menno van der Eerden
    ERJ Open Research Oct 2018, 4 (4) 00136-2018; DOI: 10.1183/23120541.00136-2018
  • Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD
    Katherine J. Baines, Thomas K. Wright, Peter G. Gibson, Heather Powell, Philip M. Hansbro, Jodie L. Simpson
    ERJ Open Research Oct 2018, 4 (4) 00031-2018; DOI: 10.1183/23120541.00031-2018
  • Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice
    Sophie V. Fletcher, Mark G. Jones, Elizabeth A. Renzoni, Helen Parfrey, Rachel K. Hoyles, Katherine Spinks, Maria Kokosi, Apollinaris Kwok, Chris Warburton, Vanessa Titmuss, Muhunthan Thillai, Nicola Simler, Toby M. Maher, Christopher J. Brereton, Felix Chua, Athol U. Wells, Luca Richeldi, Lisa G. Spencer
    ERJ Open Research Oct 2018, 4 (4) 00049-2018; DOI: 10.1183/23120541.00049-2018
  • Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study
    Vincent Cottin, Dirk Koschel, Andreas Günther, Carlo Albera, Arata Azuma, C. Magnus Sköld, Sara Tomassetti, Philip Hormel, John L. Stauffer, Indiana Strombom, Klaus-Uwe Kirchgaessler, Toby M. Maher
    ERJ Open Research Oct 2018, 4 (4) 00084-2018; DOI: 10.1183/23120541.00084-2018
  • The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites
    Elena K. Schneider, Rachel M. McQuade, Vincenzo C. Carbone, Felisa Reyes-Ortega, John W. Wilson, Brenda Button, Ayame Saito, Daniel P. Poole, Daniel Hoyer, Jian Li, Tony Velkov
    ERJ Open Research Jan 2018, 4 (1) 00127-2017; DOI: 10.1183/23120541.00127-2017
  • Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study
    John H. Riley, Chris J. Kalberg, Alison Donald, David A. Lipson, Muhammad Shoaib, Lee Tombs
    ERJ Open Research Jan 2018, 4 (1) 00073-2017; DOI: 10.1183/23120541.00073-2017

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Acute lung injury and critical care (21)
  • Asthma and allergy (108)
  • CF and non-CF bronchiectasis (71)
  • COPD and smoking (186)
  • Epidemiology, occupational and environmental lung disease (42)
  • Genetics (12)
  • Interstitial and orphan lung disease (93)
  • Lung biology and experimental studies (43)
  • Lung cancer (51)
  • Lung imaging (24)
  • Lung structure and function (47)
  • Mechanisms of lung disease (4)
  • Paediatric pulmonology (53)
  • Pulmonary pharmacology and therapeutics (58)
  • Pulmonary vascular disease (36)
  • Respiratory clinical practice (69)
  • Respiratory infections and tuberculosis (161)
  • Sleep medicine (37)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series
  • COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society